Mohan S, Chest V, Chadwick R B, Wergedal J E, Srivastava A K
Musculoskeletal Disease Center (151), Loma Linda VA Healthcare Systems, Loma Linda, CA 92357, USA.
Bone. 2007 Nov;41(5):860-8. doi: 10.1016/j.bone.2007.07.016. Epub 2007 Aug 7.
Phenotype-driven mutagenesis approach in the mouse holds much promise as a method for revealing gene function. Earlier, we have described an N-ethyl-N-nitrosourea (ENU) mutagenesis screen to create genome-wide dominant mutations in the mouse model. Using this approach, we describe identification of two high bone density mutants in C57BL/6J (B6) background. The mutants, named as 12184 and 12137, have been bred more than five generations with wild-type B6 mice, each producing >200 backcross progeny. The average total body areal bone mineral density (aBMD) was 13-17% higher in backcrossed progeny from both mutant lines between 6 and 10 weeks of age, as compared to wild-type (WT) B6 mice (n=60-107). At 3 weeks of age the aBMD of mutant progeny was not significantly affected as compared to WT B6 mice. Data from 10- and 16-week old progeny show that increased aBMD was mainly related to a 14-20% higher bone mineral content, whereas bone size was marginally increased. In addition, the average volumetric BMD (vBMD) was 5-15% higher at the midshaft tibia or femur, as compared to WT mice. Histomorphometric analysis revealed that bone resorption was 23-34% reduced in both mutant mice. Consistent with histomorphometry data, the mRNA expression of genes that regulate osteoclast differentiation and survival were altered in the 12137 mutant mice. To determine the chromosomal location of the ENU mutation, we intercrossed both mutant lines with C3H/HeJ (C3H) mice to generate B6C3H F2 mice (n=164 for line 12137 and n=137 F2 for line 12184). Interval mapping using 60 microsatellite markers and aBMD phenotype revealed only one significant or suggestive linkage on chromosome 4. Since body weight was significantly higher in mutant lines, we also used body weight as additive and interactive covariate for interval mapping; both analyses showed higher LOD scores for both 12137 and 12184 mutants without affecting the chromosomal location. The large phenotype in the mutant mice compared to generally observed QTL effects (<5%) would increase the probability of identifying the mutant gene.
在小鼠中,基于表型的诱变方法作为一种揭示基因功能的手段具有很大潜力。此前,我们描述了一种N-乙基-N-亚硝基脲(ENU)诱变筛选方法,用于在小鼠模型中创建全基因组显性突变。利用这种方法,我们描述了在C57BL/6J(B6)背景下鉴定出两个高骨密度突变体。这两个突变体分别命名为12184和12137,已与野生型B6小鼠回交了五代以上,每代产生超过200个回交后代。与野生型(WT)B6小鼠(n = 60 - 107)相比,两个突变系的回交后代在6至10周龄时平均全身面积骨矿物质密度(aBMD)高出13 - 17%。在3周龄时,突变后代的aBMD与WT B6小鼠相比没有显著差异。来自10周龄和16周龄后代的数据表明,aBMD增加主要与骨矿物质含量高14 - 20%有关,而骨大小略有增加。此外,与WT小鼠相比,在胫骨或股骨中段的平均体积骨密度(vBMD)高出5 - 15%。组织形态计量学分析显示,两个突变小鼠的骨吸收减少了23 - 34%。与组织形态计量学数据一致,在12137突变小鼠中,调节破骨细胞分化和存活的基因的mRNA表达发生了改变。为了确定ENU突变的染色体位置,我们将两个突变系与C3H/HeJ(C3H)小鼠杂交,以产生B6C3H F2小鼠(12137系n = 164,12184系n = 137 F2)。使用60个微卫星标记和aBMD表型进行区间定位,结果仅在4号染色体上发现一个显著或提示性的连锁。由于突变系的体重显著更高,我们还将体重用作区间定位的加性和交互协变量;两种分析均显示12137和12184突变体的LOD得分更高,且不影响染色体位置。与通常观察到的数量性状位点效应(<5%)相比,突变小鼠中的大表型将增加鉴定突变基因的概率。